Can Fite Biopharma ADR Representing 300 Ord Shs (CANF) has risen Wednesday morning, with the stock adding 3.27% in pre-market trading to 2.21.
CANF's short-term technical score of 38 indicates that the stock has traded less bullishly over the last month than 62% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, Can Fite Biopharma ADR Representing 300 Ord Shs ranks higher than 57% of stocks.
Can Fite Biopharma ADR Representing 300 Ord Shs has risen 3.88% over the past month, closing at $1.91 on October 25. During this period of time, the stock fell as low as $1.90 and as high as $2.19. CANF has an average analyst recommendation of Strong Buy. The company has an average price target of $12.00.
CANF has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on CANF!
Can Fite Biopharma ADR Representing 300 Ord Shs has a Long-Term Technical rank of 8. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 92% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, CANF ranks better than 131% of stocks.
